B-BRIGHTER project was present at the third edition of the EMBL-IBEC conference in Barcelona through the participation of Levin Hafa and Louise Breideband from GUF. This event, organized by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL), has it focus on emerging and advanced therapies.
The third edition of the EMBL-IBEC Conference on Engineering Multicellular Systems took place at the
Barcelona Biomedical Research Park (PRBB) in Barcelona last 24, 25 and 26 April. This biennial conference focuses on emerging and advanced therapies and addresses the state-of-the-art advances in emerging fields of bioengineering, such as organ-on-chip, cell mechanobiology, stem cell biology, and 3D bioprinting, and how all these advances have revolutionized our ability to design and assemble multicellular living systems, from organoids to embryos.
This year, the conference featured 20 invited experts from Europe, Canada, USA, Japan and India, and brought together around 150 international experts in different fields of bioengineering, who spent three days discussing the forefront research on engineering of multicellular living systems.
In the context of this event, Louise Breideband presented a poster titled “Upgrading a Consumer Stereolithographic 3D Printer to Produce Physiologically Relevant Cancer Models”, showcasing the open-source device based on a consumer-grade 3D stereolithography apparatus (SLA) printer, developed in the frame of B-BRIGHTER project.
On the other hand, Levin Hafa presented a poster that was also selected for a short talk, titled “Laser patterning bioprinting using a light sheet-based system equipped with light sheet imaging produces long-term viable full-thickness skin constructs”. This presentation summarizes the work being done in the project as well as the main results obtained to date.
The EMBL-IBEC Conference on Engineering Multicellular Systems is being consolidated in Barcelona as an international benchmark, shedding light on the function of tissues and organs, with applications in drug modelling, disease detection and tissue engineering, and their applications in advanced therapies.